Please try another search
China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the blood products, and biochemical and chemical drugs businesses in China and internationally. It offers blood products comprising human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, human albumin, and human immunoglobulin; non-blood products, including metformin hydrochloride enteric-coated tablets, pioglitazone hydrochloride dispersible tablets, glipizide tablets, glimepiride tablets, pioglitazone hydrochloride dispersible tablets, simvastatin tablets, and calcium dobesilate capsules. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co., Ltd. The company was founded in 1993 and is based in Fuzhou, China.
Name | Age | Since | Title |
---|---|---|---|
Huasheng Huang | - | 2021 | Independent Director |
Li Zhao | - | 2021 | Independent Director |
Weidong Zhang | 60 | 2021 | Independent Director |
Shao Qing Shao | - | - | Supervisor |
Guiling Tan | 57 | 2017 | Non-Employee Representative Supervisor |
Yuxuan Pan | 40 | 2024 | Director |
Xiaoming Liang | 57 | 2021 | President & Director |
Zhen Rao | 56 | 2021 | Employee Representative Supervisor |
Kai Qiu | 55 | 2023 | Chairman of the Board |
Huacheng Liang | 42 | 2021 | VP, CFO, Secretary & Director |
Jinfeng Shen | 48 | 2023 | Director |
Na Tang | 48 | 2021 | Chairman of Supervisory Board |
Jinni Sun | 41 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review